Ropivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ropivacaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 03/23/2018.
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 65219-632-20
- Dosage Form
- Injection
- Presentation
- Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)
- Initial Posting
- 03/23/2018
- Revised Date